Market revenue in 2023 | USD 507.7 million |
Market revenue in 2030 | USD 2,221.7 million |
Growth rate | 23.5% (CAGR from 2023 to 2030) |
Largest segment | Instruments |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Agilent Technologies Inc, Illumina Inc, Qiagen NV, Roche Holding AG, Macrogenics Inc, PerkinElmer, Pacific Biosciences of California Inc, BGI Group, BGC Group Inc Ordinary Shares Class A, Bio-Rad Laboratories Inc, Myriad Genetics Inc, PierianDx, Eurofins Scientific SE |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna sequencing market will help companies and investors design strategic landscapes.
Instruments was the largest segment with a revenue share of 49.62% in 2023. Horizon Databook has segmented the Canada dna sequencing market based on consumables, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.
Canada DNA sequencing market is expected to register significant growth during the forecast period owing to ongoing initiatives for developments and advancements undertaken by institutions such as Ontario University for development of molecular and companion diagnostics using NGS. Moreover, Canadian researchers are employing genome sequencing to track various infectious diseases.
For instance, in December 2020, Genome sequencing is being used by infectious disease researchers at McMaster University in Hamilton, Ontario to detect COVID-19 variations. Such initiatives are expected to increase genome sequencing techniques, thereby boosting NGS adoption in the country.
Furthermore, growing technological advancements in applications, such as noninvasive prenatal testing and largescale population sequencing projects, are expected to drive the market in Canada over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada dna sequencing market , including forecasts for subscribers. This country databook contains high-level insights into Canada dna sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account